Heterocyclic derivatives as opioid modulators

Details for Australian Patent Application No. 2011202364 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Breslin, Henry Joseph; Kavash, Robert W.; He, Wei

Agent Shelston IP

Pub. Number AU-B-2011202364

Parent 2009233679

Filing date 20 May 2011

Wipo publication date 9 June 2011

Acceptance publication date 20 September 2012

International Classifications

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4439

A61K 31/454

A61K 31/4725

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 1/10 Drugs for disorders of the alimentary tract or the digestive system

A61P 25/04 Drugs for disorders of the nervous system

C07D 217/26 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

9 June 2011 Application Open to Public Inspection

  Published as AU-B-2011202364

9 June 2011 Complete Application Filed

20 September 2012 Application Accepted

  Published as AU-B-2011202364

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202365-Concentrator photovoltaic device

2011202363-Kelly for the realization of bored piles